Request a sample issue at the Sample Issue Page
Sample Articles from IJPC
About IJPC
The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.
The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.
Search the Journal by issue, topic or keyword
Request a free copy of the Journal
Material printed in IJPC is covered by copyright. All rights reserved. See the Reprints and Permissions Page for more information.
A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included. The URL for this item is http://www.ijpc.com/Sample/Article.cfm?SID=94 The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.
Download
"Disposing of Expired Drugs and Chemicals: New Options for Compounders"
Please provide the following and click the submit button
 |
|
|
|
|
|
| Keyword Results for disposal expired drugs services | |||||
| Page | Title | Author | Issue | ||
| 38-47 | Disposing of Expired Drugs and Chemicals: New Options for Compounders | Vail Jane | View Sample | Abstract | Jan/Feb 2008 |
| 87 | PostScription: Consumer Options for Disposal of Unused Medications | Vail Jane | Buy | Jan/Feb 2008 | |
| 366-369 | Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response | Briggs Valerie | Buy | Abstract | Sep/Oct 2010 |
| 210 | Standard Operating Procedure: Disposal of Chemicals | Allen Loyd V Jr | Buy | Abstract | May/Jun 2004 |
| 101 | Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs | Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K | Buy | Abstract | Mar/Apr 2004 |
| 377-378 | Ambulatory Care Medicine: Definition and Scope of Service | Wenmark William H | Buy | Abstract | Nov/Dec 1997 |
| 175-183 | The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States | Stephenson Kenna, Jones William, Stephenson Douglas M M | Buy | Abstract | May/Jun 2006 |
| 44-46 | The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") | Allen Loyd V Jr, Ashworth Lisa D | Buy | Abstract | Jan/Feb 2005 |
| 101 | Drugs Banned for Use in Food Animals: An Explanation | Davidson Gigi S | Buy | Abstract | Mar/Apr 2001 |
| 140-144 | Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing | Douglass Kate, Kastango Eric S | Buy | Mar/Apr 2001 | |
| 19-20 | Compounding Pharmacy: A Unique Service for a Unique Population | Williams LaVonn A, Franck Paul | Buy | Abstract | Jan/Feb 2010 |
| 180 | Compounding OTC Drugs: A Legal Perspective | Gibbs Jeffrey N, Mazan Kate Duffy | Buy | Abstract | May/Jun 2000 |
| 97 | Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding | Chan Debora Schotik | Buy | Abstract | Mar/Apr 2001 |
| 74-82 | Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists | Huffman DC, Holmes Erin R | Buy | Abstract | Jan/Feb 2008 |
| 188 | Wish You Were Here: Oklahoma Frontier Drug Store Museum | Worthen Dennis B | Buy | Abstract | May/Jun 2000 |
| 36 | Developing and Providing Compounding Services for Hospitals Involved in a Merger | McElhiney Linda F | Buy | Abstract | Jan/Feb 2004 |
| 271-273 | Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer | Kramer Mark A, Grilley Bambi J | Buy | Jul/Aug 2002 | |
| 311-315 | Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs | Trissel Lawrence A, Saenz Christopher | Buy | Abstract | Jul/Aug 2002 |
| 121-122 | Compatibility of Common Respiratory Therapy Drug Combinations, The | Owsley Heather D, Rusho William F, | Buy | Abstract | Mar/Apr 1997 |
| 150-151 | Drug Products and Drug Packaging for the Elderly | Allen Loyd V Jr | Buy | Abstract | May/Jun 1997 |
| 44 | Determining the Availability of a Commercial Drug | Buy | Abstract | Jan/Feb 2003 | |
| 426-432 | Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion | Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A | Buy | Abstract | Sep/Oct 2007 |
| 400-403 | Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications | Gilbert John A | Buy | Abstract | Sep/Oct 2009 |
| 131-133 | Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs | Burke John, Hill Jeff | Buy | Abstract | Mar/Apr 2010 |
| 350-351 | PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 | Allen Loyd V Jr | Buy | Jul/Aug 2007 | |
| 446-448 | Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2006 |
| 56-62 | Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs | Allen Loyd V Jr, Okeke Claudia C | Buy | Abstract | Jan/Feb 2009 |
| 14-18 | Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports | Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George | Buy | Abstract | Jan/Feb 2009 |
| 384-390 | Canine Public Servants: Caring for Drug Detection Dogs | Davidson Gigi S | Buy | Abstract | Sep/Oct 2008 |
| 276-278 | Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration | Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A | Buy | Abstract | May/Jun 2008 |
| 230-233 | Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration | Trusley Craig, Kupiec Thomas C, Trissel Lawrence A | Buy | Abstract | May/Jun 2006 |
| 282-286 | Premarin: The Intriguing History of a Controversial Drug | Vance Dwight A | Buy | Abstract | Jul/Aug 2007 |
| 56-58 | Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding | Anderson Derick | Buy | Abstract | Jan/Feb 2007 |
| 69-72 | Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs | Trissel Lawrence A, Williams Kimberly Y, Baker Ma | Buy | Abstract | Jan/Feb 2001 |
| 11 | Problem of Drug Diversion, The | Burke John J | Buy | Abstract | Jan/Feb 2002 |
| 321-324 | Rapid Pharmacokinetic Evaluation of Topical Drug Formulations | Garzouzi Victoria L, Reifenrath William G | Buy | Abstract | Jul/Aug 1999 |
| 261 | Compounding Using Hazardous Drugs | Lau Kellie | Buy | Abstract | Jul/Aug 2000 |
| 267-270 | Facilities and Procedures for Compounding Hazardous Drugs | Rahe Hank | Buy | Jul/Aug 2002 | |
| 123 | An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs | Monnot Chris L | Buy | Abstract | Mar/Apr 2004 |
| 338 | Drug Therapy for Acute and Chronic Pain in the Cat | Lascelles B Duncan | Buy | Abstract | Sep/Oct 2002 |
| 234-237 | Preparation and Evaluation of Sustained Drug Release from Pluronic Polyol Rectal Suppositories | Anderson Derick, Amiji Mansoor M | Buy | Abstract | May/Jun 2001 |
| 230-233 | Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs | Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P | Buy | Abstract | May/Jun 2002 |
| 292-293 | Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 2004 |
| 21 | Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center | Vail Jane | Buy | Abstract | Jan/Feb 2003 |
| 438-439 | PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 | Allen Loyd V Jr | Buy | Sep/Oct 2007 | |
| 201-205 | Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs | Harrington Catherine A, Cauffield Jacintha | Buy | Abstract | May/Jun 2005 |
| 377-379 | Basics of Compounding for Hazardous Drugs, Part 1: An Introduction | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2006 |
| 149-151 | Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations | Allen Loyd V Jr | Buy | Abstract | Mar/Apr 2007 |
| 107-109 | Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. | Allen Loyd V Jr | Buy | Abstract | Mar/Apr 2004 |
| 26-31 | Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging | Biundo Bruce | Buy | Abstract | Jan/Feb 2010 |
| 162-165 | Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers | Aloumanis Vasileios, Ben Michel, Kupiec Thomas C, Trissel Lawrence A | Buy | Abstract | Mar/Apr 2009 |
| 241-244 | Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration | Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C | Buy | Abstract | May/Jun 1999 |
| 190 | Three Drug Stability Lives | Newton David W | Buy | Abstract | May/Jun 2000 |
| 439 | Electronically Controlled Drug Delivery | Kloesel Lawson | Buy | Abstract | Nov/Dec 1999 |
| 356-358 | Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions | Martinez Juan F, Trissel Lawrence A, Gilbert Doward L Jr | Buy | Abstract | Sep/Oct 1997 |
| 347-349 | TPN Bulk Compounding from Bulk Drug Substances | Chamallas Stanley N | Buy | Abstract | Sep/Oct 1998 |
| 496-500 | Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations | Goodwin Donald A, Fuhram L Clifton | Buy | Abstract | Nov/Dec 1999 |
| 314-319 | Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration | Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S | Buy | Abstract | Jul/Aug 2001 |
| 229 | Animal Drug Delivery Systems | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 1997 |
| 390-395 | Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients | Davidson Gigi S | Buy | Abstract | Sep/Oct 2007 |
| 80 | PostScription: Stopping Drug Reps at the Door | Brewer Benjamin | Buy | Jan/Feb 2006 | |
| 450-451 | Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies | Allen Loyd V Jr | Buy | Nov/Dec 2006 | |
| 115 | Marketing Your Prescription Compounding Practice: Part Two | Letendre William R, Jackson Richard A | Buy | Abstract | Mar/Apr 2000 |
| 301-305 | Drug Stability and Compatibility: Special Considerations for Home Health Care | Lima Hetty A | Buy | Abstract | Sep/Oct 1997 |
| 251 | A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards | Newton David W, Trissel Lawrence A | Buy | Abstract | Jul/Aug 2004 |
| 173 | Book Reviews: Veterinary Drug Handbook: Client Information Edition | Reed-Kane Dana | Buy | May/Jun 2005 | |
| 242-246 | Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study | Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D | Buy | Abstract | May/Jun 2005 |
| 6 | Pediatric Compounding: Coloring Outside the Lines | Preckshot John | Buy | Abstract | Jan/Feb 2001 |
| 309 | Acidifying Agents, Featured Excipient: | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 1999 |
| 288 | Book Reviews | Reed-Kane Dana | Buy | Jul/Aug 2000 | |
| 300-310 | Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting | McElhiney Linda F | Buy | Abstract | Jul/Aug 2009 |
| 20-25 | Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!" | McElhiney Linda F | Buy | Abstract | Jan/Feb 2009 |
| 322-326 | Basics of Compounding: Basics of Compounding with Organic Salts | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 2010 |
| 50-51 | Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2007 |
| 462-468 | Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists | Huffman DC, Holmes Erin R | Buy | Abstract | Nov/Dec 2006 |
| 108-109 | Book Reviews: Veterinary Compounding | Reed-Kane Dana | Buy | Mar/Apr 2001 | |
| 441 | Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care | Fassett William E | Buy | Abstract | Nov/Dec 2003 |
| 231-235 | Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. | Trissel Lawrence A, Zhang Yanping | Buy | Abstract | May/Jun 2004 |
| 83-88 | Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane | Tenjarla Srini N, Ward Earl S, Fox Janet L | Buy | Abstract | Jan/Feb 1998 |
| 13 | Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective | Vail Jane | Buy | Abstract | Jan/Feb 2002 |
| 78-81 | Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam | Veggeland Turid, Brandl Martin | Buy | Abstract | Jan/Feb 2010 |
| 326-327 | Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration | Kupiec Tom, Kemp Jesse | Buy | Jul/Aug 2007 | |
| 128-136 | Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations | Okeke Claudia C | Buy | Abstract | Mar/Apr 2009 |
| 365-367 | Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada | Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise | Buy | Abstract | Jul/Aug 2008 |
| 375 | PostScription: It Is Not Just What You Say…But How You Say It! | Reed-Kane Dana | Buy | Jul/Aug 2008 | |
| 284 | PreScription: First Estriol, Then What? | Allen Loyd V Jr | Buy | Jul/Aug 2008 | |
| 498-504 | Case Reports: Compounding to Relieve Arthritis Pain | Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane | Buy | Abstract | Nov/Dec 2008 |
| 524-528 | Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations | Trissel Lawrence A | Buy | Abstract | Nov/Dec 2008 |
| 329-333 | Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature | Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie | Buy | Abstract | Jul/Aug 2008 |
| 254 | Sterile Compounding with Barrier-Isolation Technology | Rahe Hank | Buy | Abstract | Jul/Aug 2001 |
| 120 | Parenteral Admixtures Requiring Select Containers and Administration Sets, A Review of | Rice Stephen P | Buy | Abstract | Mar/Apr 2002 |
| 188 | When is Compounding for Animals Legal? | Siegner A Wes Jr | Buy | Abstract | May/Jun 1999 |
| 449-450 | Is Veterinary Compounding Illegal Under Federal Law? | Gibbs Jeffrey N | Buy | Abstract | Nov/Dec 2004 |
| 188 | Treating Canine Hepatic Disease | Davidson Gigi S | Buy | Abstract | May/Jun 2003 |
| 358 | NDC Numbers: A New Approach | Heckman H Edward | Buy | Abstract | Sep/Oct 2003 |
| 240 | PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! | Mason Dave | Buy | May/Jun 2006 | |
| 323-326 | Stability of Nebulizer Admixtures | Blondino Frank E, Baker Matthew | Buy | Abstract | Jul/Aug 2005 |
| 93-94 | Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer | Reed-Kane Dana | Buy | Mar/Apr 2005 | |
| 220-225 | Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 | Giacoia George P, Taylor-Zapata Perdita, Mattison Donald | Buy | Abstract | May/Jun 2007 |
| 200 | Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain | Fields Shannon W | Buy | Abstract | May/Jun 2007 |
| 153 | Standard Operating Procedure: Discarding of Broken Glass | Allen Loyd V Jr | Buy | Mar/Apr 2007 | |
| 238-241 | Litigating the Legality of Compounding: The Medical Center Pharmacy Case | Gibbs Jeffrey N | Buy | Abstract | May/Jun 2008 |
| 414-415 | Standard Operating Procedure: Complaint and Mishap Rectification | Allen Loyd V Jr | Buy | Sep/Oct 2007 | |
| 213-214 | What Customers Want | Roberts Jerrod L | Buy | Abstract | May/Jun 2005 |
| 46-49 | How'd They Do That? | Roberts Jerrod L | Buy | Abstract | Jan/Feb 2006 |
| 197 | Value and Pricing: Figuring Out What You're Worth | Capps Shelly | Buy | Abstract | May/Jun 1999 |
| 36 | Marketing Your Prescription Compounding Practice: Part One | Letendre William R, Jackson Richard A | Buy | Abstract | Jan/Feb 2000 |
| 40 | Profile of a Practice | Davis Jeanie Lerche | Buy | Abstract | Jan/Feb 2000 |
| 124-128 | Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes | Shuey Brandon, Williams LaVonn A | Buy | Abstract | Mar/Apr 2010 |
| 537-538 | Branding: Give Your Small Business a Big Image | Storey Patricia L | Buy | Abstract | Nov/Dec 2008 |
| 540 | Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2008 |
| 541 | Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2008 |
| 553-557 | Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration | Shields David E, Aclan Jennifer, Szatkowski Aaron | Buy | Abstract | Nov/Dec 2008 |
| 6-12 | Compounding for Pediatric Patients: Case Reports and Formulations | Mixon William, Angelle Patricea, Yoch Douglas | Buy | Abstract | Jan/Feb 2009 |
| 42-49 | Compounding for Cancer in Companion Animals | Mixon William, Northrup Nicole, Vail Jane | Buy | Abstract | Jan/Feb 2009 |
| 78-80 | Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration | Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel | Buy | Abstract | Jan/Feb 2009 |
| 259-261 | Formulation Optimization Study for an Immediate-Release Tablet | Kyriacos Soula, Dimassi Hani | Buy | Abstract | May/Jun 2009 |
| 182-190 | Update on Managing Neuropathic Pain | McNulty Jack P, Muller George | Buy | Abstract | May/Jun 2009 |
| 218-219 | Safe Use of Topical Local Anesthetic Medications for Pain Management | Epshteyn Mikhail G, Pepin Steven M | Buy | May/Jun 2009 | |
| 372-381 | A Review of Stomatitis and Treatment in Cats | Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E | Buy | Abstract | Sep/Oct 2009 |
| 386-389 | Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses | Williams LaVonn A, Fokken Dawn | Buy | Abstract | Sep/Oct 2009 |
| 404-409 | An Abridged History of Aspirin | Vance Dwight A | Buy | Abstract | Sep/Oct 2009 |
| 543 | Indomethacin 2% in Pluronic Lecithin Organogel | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2008 |
| 544 | Ketorolac Tromethamine 2% Topical Gel | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2008 |
| 286-292 | Estriol: Women's Choice vs. A Manufacturer's Greed | Goodrum Jennifer | Buy | Abstract | Jul/Aug 2008 |
| 446 | Aceclofenac 1.5% Gel-Cream | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2008 |
| 460-462 | Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration | Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A | Buy | Abstract | Sep/Oct 2008 |
| 463-466 | Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration | Shields David E, Aclan Jennifer, Szatkowski Aaron | Buy | Abstract | Sep/Oct 2008 |
| 414-418 | Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers | Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie | Buy | Abstract | Sep/Oct 2008 |
| 426-430 | Excipient Choices for Special Populations | Nagel-Edwards Karen M, Ko James Y | Buy | Abstract | Sep/Oct 2008 |
| 432-433 | Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations | Cabaleiro Joe | Buy | Abstract | Sep/Oct 2008 |
| 452 | Ketoprofen 20% Topical Solution | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2008 |
| 454 | Piroxicam 5% and Dexpanthenol 5% Gel | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2008 |
| 105-107 | Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? | Williams LaVonn A | Buy | Abstract | Mar/Apr 2010 |
| 328-331 | Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program | Okeke Claudia C, Allen Loyd V Jr | Buy | Abstract | Jul/Aug 2010 |
| 341 | Flurbiprofen 5% Bioadhesive Gel for Gingivitis | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 2010 |
| 368-371 | Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration | Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A | Buy | Abstract | Jul/Aug 2008 |
| 438-439 | Chemical Stability of Scopolamine Hydrobromide Nasal Solution | Gupta Vishnu D | Buy | Abstract | Sep/Oct 2009 |
| 440-444 | Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study | Haywood Alison, Bolitho Richard, Gusti Kane, Yim Crystal, Testa Chris, Hattingh Laetitia | Buy | Abstract | Sep/Oct 2009 |
| 68 | Ketoprofen 100-mg/5-mL Mouth Rinse | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2010 |
| 75 | Trigger Point Gel | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2010 |
| 74 | Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2010 |
| 174-175 | PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? | Allen Loyd V Jr, Burger Mark | Buy | Mar/Apr 2010 | |
| 180 | PreScription: Healthcare Reform Is Not All That Is Happening in Washington | Menighan Thomas E | Buy | May/Jun 2010 | |
| 200-203 | Topical Medications for Orofacial Neuropathic Pain | Bramwell Bethany L | Buy | Abstract | May/Jun 2010 |
| 204-206 | Managing Pain with Transdermal Ketoprofen | Williams KaCee D | Buy | Abstract | May/Jun 2010 |
| 241 | Carprofen 2.5-mg/mL Oral Suspension, Veterinary | Allen Loyd V Jr | Buy | Abstract | May/Jun 2010 |
| 242 | Celecoxib 10-mg/mL Oral Suspension | Allen Loyd V Jr | Buy | Abstract | May/Jun 2010 |
| 218-221 | Quality Control Analytical Methods: Continuous Quality Improvement | Odegard Russell D | Buy | Abstract | May/Jun 2010 |
| 270-274 | Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together | McElhiney Linda F | Buy | Abstract | Jul/Aug 2010 |
| 276-282 | Recommendations for Compounding Medications for Feeding Tube Administration | Klang Mark | Buy | Abstract | Jul/Aug 2010 |
| 310-314 | Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser | Christiansen Joel, White Lyndell | Buy | Abstract | Jul/Aug 2010 |
| 25 | Book Reviews: Stability and Formulation References | Allen Loyd V Jr | Buy | Jan/Feb 2001 | |
| 274 | Extemporaneous Formulations in Pediatric Patients | Nahata Milap C | Buy | Abstract | Jul/Aug 1999 |
| 312-313 | Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules | Allen Loyd V Jr | Buy | Abstract | Jul/Aug 1999 |
| 200 | BPS Pharmacy Specialty Certification Program, The | Bertin Richard J | Buy | Abstract | May/Jun 1999 |
| 90-92 | Flavors and Flavoring | Allen Loyd V Jr | Buy | Abstract | Mar/Apr 1997 |
| 88 | Natural Testosterone: Hormone of the Heart | Wright Jonathan V, Lenard Lane | Buy | Abstract | Mar/Apr 1999 |
| 126-127 | Report: USP Expert Advisory Panel on Pharmacy Compounding Practices | Allen Loyd V Jr | Buy | Abstract | Mar/Apr 1999 |
| 146-147 | Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids | Allen Loyd V Jr | Buy | Abstract | Mar/Apr 1999 |
| 160-163 | In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 | Foldvari Marianna, Oguejifor Cosmas | Buy | Abstract | Mar/Apr 1999 |
| 88-90 | Complications of Diabetes | Key David M | Buy | Mar/Apr 2000 | |
| 362 | Basics of Compounding: Phonophoresis | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2002 |
| 170 | Five Compounds for Treating Diabetes-Related Conditions | Meece Jerry | Buy | Abstract | May/Jun 2003 |
| 376-380 | Basics of Compounding for Skin Discolorations | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2004 |
| 452 | Basics of Compounding - Inhalation Preparations | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2000 |
| 434-437 | Regulatory and Operational Issues of Founding a Compounding Pharmacy | Smith Lisa K | Buy | Nov/Dec 2002 | |
| 443-447 | Basics of Compounding: Clinical Studies | Allen Loyd V Jr | Buy | Nov/Dec 2002 | |
| 458 | When Problem Audits Strike | Heckman H Edward | Buy | Abstract | Nov/Dec 1999 |
| 204-205 | The Future of Compounding: An Industry Perspective | Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A | Buy | Abstract | May/Jun 2000 |
| 26-27 | Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis | Fields Shannon W | Buy | Jan/Feb 2007 | |
| 426-427 | Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard) | Benischek Rita L, Riffell Gregory S, Mauldin Todd | Buy | Nov/Dec 2006 | |
| 36-41 | Information Resources and Software for the Hospital Compounding Pharmacist | McElhiney Linda F | Buy | Abstract | Jan/Feb 2007 |
| 291-292 | Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight | Vail Jane | Buy | Abstract | Jul/Aug 2006 |
| 351 | Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches | Williams Steve D | Buy | Sep/Oct 2006 | |
| 154-155 | Chemical Stability of Diclofenac Sodium Injection | Gupta Vishnu D | Buy | Abstract | Mar/Apr 2006 |
| 428-433 | BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle | Benischek Rita L | Buy | Abstract | Nov/Dec 2006 |
| 434-435 | Ronidazole in the Treatment of Trichomonad Infections in Cats | Davidson Gigi S | Buy | Abstract | Nov/Dec 2006 |
| 458 | Indomethacin 2-mg/mL Oral Liquid | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2006 |
| 459 | Naltrexone 1-mg/mL Oral Liquid | Allen Loyd V Jr | Buy | Abstract | Nov/Dec 2006 |
| 178-182 | Update on Transdermals for Animal Patients | Davidson Gigi S | View Sample | Abstract | May/Jun 2005 |
| 167 | PostScription: Experts Everywhere | Rahe Hank | Buy | Abstract | Mar/Apr 2005 |
| 68 | Naproxen Sodium 100-mg/mL Injection | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2005 |
| 14-18 | Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery | Heim Bob | View Sample | Abstract | Jan/Feb 2006 |
| 20-28 | Pharmaceutical Legislation: An Historical Perspective | Worthen Dennis B | Buy | Abstract | Jan/Feb 2006 |
| 32-34 | Pharmacy Compounding Urban Legends | Kastango Eric S | Buy | Abstract | Jan/Feb 2006 |
| 234-236 | Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration | Trissel Lawrence A, Xu Quanyun A, Zhang Yanping | Buy | Abstract | May/Jun 2006 |
| 237-239 | Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together | Gupta Vishnu D | Buy | Abstract | May/Jun 2006 |
| 416 | Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2007 |
| 421 | Diclofenac Sodium 75-mg/mL Injection | Allen Loyd V Jr | Buy | Abstract | Sep/Oct 2007 |
| 83-85 | Room Temperature Stability of Injectable Succinylcholine Dichloride | Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice | Buy | Abstract | Jan/Feb 2008 |
| 247-251 | A Process Verification Model for Quality Assurance in a Compounding Pharmacy | Zolner William J | Buy | Abstract | May/Jun 2008 |
| 264 | Meloxicam 0.3% Topical Gel | Allen Loyd V Jr | Buy | Abstract | May/Jun 2008 |
| 180 | PreScription: Pain! | Allen Loyd V Jr | Buy | May/Jun 2008 | |
| 487-490 | Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds | Trusley Craig | Buy | Abstract | Nov/Dec 2007 |
| 520-524 | Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration | Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A | Buy | Abstract | Nov/Dec 2007 |
| 8-14 | Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration | Dib Jean G, Abdulmohsin Saud | Buy | Abstract | Jan/Feb 2008 |
| 65 | Diclofenac Sodium 1% Soft-Patch Gel | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2008 |
| 66 | Diclofenac Sodium 1% Soft-Patch Lipophilic Gel | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2008 |
| 54-60 | Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations | Allen Loyd V Jr, Okeke Claudia C | Buy | Abstract | Jan/Feb 2008 |
| 71 | Piroxicam 1% Soft-Patch Lipophilic Gel | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2008 |
| 72 | Piroxicam 1% Soft-Patch Topical Gel | Allen Loyd V Jr | Buy | Abstract | Jan/Feb 2008 |
| 88 | PostScription: IJPC—More Than a Journal | Buy | Jan/Feb 2007 | ||
| 202-211 | Levorphanol for the Treatment of Severe Chronic Pain | McNulty Jack P | Buy | Abstract | May/Jun 2007 |
| 181-184 | Transdermal Gel in the Treatment of Postoperative Pain | Alexander Kayla, Wynn Tom | Buy | Abstract | May/Jun 2007 |
| 404-410 | Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels | Allen Loyd V Jr, Okeke Claudia C | Buy | Abstract | Sep/Oct 2007 |
| 376-383 | The Whales: A Pharmacist's Story | Wills William R | Buy | Abstract | Sep/Oct 2007 |
| 300 | Book Review: The Rexall Story: A History of Genius and Neglect | Grajeda Betty Jo | Buy | Jul/Aug 2007 | |
| 278-281 | The Politics of Hormone Replacement Therapy | Allen Loyd V Jr | Buy | Jul/Aug 2007 | |
| 302-305 | Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations | Okeke Claudia C | Buy | Abstract | Jul/Aug 2007 |
| 59-65 | Pharmacogenomics: The End of Trial-and-Error Medicine? | Vail Jane | Buy | Abstract | Jan/Feb 2007 |
| 5-8 | Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 | Giacoia George P, Taylor-Zapata Perdita, Mattison Donald | Buy | Abstract | Jan/Feb 2007 |